HTT and juvenile Huntington disease: In Huntington’s disease, the aggregation of polyglutamine-expanded huntingtin (HTT-polyQ) is a key pathological feature, while in ALS, aggregation of mutant FUS (mutFUS) contributes to neuronal toxicity and disease progression.